Clinical Trials Browser

Phase 2 × Thyroid Neoplasms × surufatinib × Clear all

NCT04524884 2020-08-24

Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

Phase 2 Unknown

Thyroid Neoplasms

NCT02614495 2020-02-13

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Phase 2 Completed

Thyroid Neoplasms